WASHINGTON (Reuters) - A U.S. congressional panel is asking pharmaceutical entrepreneur Martin Shkreli to testify at a Jan. 26 hearing about his company's decision to raise the price of a life-saving prescription drug, according to a Republican committee staffer.
http://ift.tt/xePdMM
from Reuters: Health News
via
animenewspro
Aucun commentaire:
Enregistrer un commentaire